Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles?
- PMID: 8392542
- DOI: 10.3109/02652049309104385
Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles?
Abstract
Beclomethasonedipropionate (BDP)-containing microparticles were prepared by the solvent evaporation/extraction method. Different preparation parameters were optimized before investigations. Polylactic acid (PLA) and polylactic/glycolic acid (PLGA) with molecular weights of 2000 and 15,000 were used as matrix polymers. In all experiments the mean diameter of the microparticles was 1-5 microns with a drug content > or = 23 per cent. Microparticles of PLA, MW 2000, showed a prolonged and complete release over 8 h, whereas those of PLGA liberated only 20 per cent of the encapsulated drug within 8 h. BDP was determined by a validated reversed-phase HPLC method with a detection limit of 20 ng/ml. The encapsulated steroid seemed to be dissolved within the polymer, as differential scanning calorimetry suggested. Considering mean particle size, drug load, release characteristics and the status of the drug inside the matrix, the dosage form showed very good characteristics for inhalatory application. Surface characteristics of the microparticles were visualized by scanning electron microscopy (SEM). Although in vitro studies with human bronchial fluid resulted in a strong deterioration of microparticles, main structures were still visible by SEM after an incubation of 36 h in diluted bronchial fluid ex vivo. Degradation in phosphate buffered saline, protein solution and even in port liver esterase suspension resulted in minor effects on the particle surface.
Similar articles
-
Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.J Control Release. 1998 Feb 12;51(2-3):327-41. doi: 10.1016/s0168-3659(97)00188-0. J Control Release. 1998. PMID: 9685930
-
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.Vaccine. 1994 Mar;12(4):299-306. doi: 10.1016/0264-410x(94)90092-2. Vaccine. 1994. PMID: 8178550
-
Determinants of release rate of tetanus vaccine from polyester microspheres.Pharm Res. 1993 Jul;10(7):945-53. doi: 10.1023/a:1018942118148. Pharm Res. 1993. PMID: 8378256
-
Biodegradation of PLA/GA polymers: increasing complexity.Biomaterials. 1994 Dec;15(15):1209-13. doi: 10.1016/0142-9612(94)90271-2. Biomaterials. 1994. PMID: 7703316 Review.
-
Use of polylactic acid for the preparation of microparticulate drug delivery systems.J Microencapsul. 1992 Apr-Jun;9(2):153-66. doi: 10.3109/02652049109021231. J Microencapsul. 1992. PMID: 1593398 Review.
Cited by
-
Lactide: Production Routes, Properties, and Applications.Bioengineering (Basel). 2022 Apr 7;9(4):164. doi: 10.3390/bioengineering9040164. Bioengineering (Basel). 2022. PMID: 35447724 Free PMC article. Review.
-
Improved activity of a new angiotensin receptor antagonist by an injectable spray-dried polymer microsphere preparation.Pharm Res. 1997 Jul;14(7):887-91. doi: 10.1023/a:1012147700014. Pharm Res. 1997. PMID: 9244145
-
The effect of cosolvents on the formulation of nanoparticles from low-molecular-weight poly(l)lactide.AAPS PharmSciTech. 2002;3(4):E32. doi: 10.1208/pt030432. AAPS PharmSciTech. 2002. PMID: 12916926 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources